Scarica l'app Stockscreener
120.09
3.07%
3.58
Pre-mercato:
119.20
-0.89
-0.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
We Think That There Are Some Issues For Illumina (NASDAQ:ILMN) Beyond Its Promising Earnings - 富途牛牛
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com
DNA Sequencing Market Is Booming So Rapidly by 2033 | Thermo Fisher Scientific, Inc., Illumina - openPR.com
Buyout Rumor: What is the Moat Score of Illumina IncMarket Performance Summary & Weekly Top Stock Performers List - baoquankhu1.vn
Illumina To Webcast Upcoming Investor Conference - cnhinews.com
Illumina, Inc. (ILMN) Stock Analysis: Evaluating a 16% Upside Potential Amidst Strong Growth Metrics - DirectorsTalk Interviews
Decoding early synaptic failure in Alzheimer’s disease through multiomic analysis - Illumina
Illumina’s AI-Driven Data Vision Is Expanding — Will Multiomics Integration Unlock a Transformational Edge? - Smartkarma
The future of global food security may depend on quality agrigenomics software - Illumina
Why Illumina Inc. stock is a must watch in 2025Weekly Gains Summary & Weekly Top Performers Watchlists - mfd.ru
How Illumina Inc. stock performs during Fed tightening cyclesDip Buying & Stepwise Entry and Exit Trade Signals - mfd.ru
Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034 - GlobeNewswire Inc.
Illumina, Inc. $ILMN Stock Holdings Lowered by Rhumbline Advisers - MarketBeat
Krilogy Financial LLC Takes $1.34 Million Position in Illumina, Inc. $ILMN - MarketBeat
How Illumina Inc. stock trades before earningsGap Down & Weekly High Return Stock Opportunities - mfd.ru
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? - Nasdaq
Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips - Nasdaq
Illumina's (NASDAQ:ILMN) Profits Appear To Have Quality Issues - Yahoo Finance
5 Insightful Analyst Questions From Illumina's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call - Yahoo Finance
Why Illumina (ILMN) Is Down 12.9% After 2026 Outlook And SomaLogic Deal CloseAnd What's Next - Sahm
Insider Buying: Scott Gottlieb Acquires Shares of Illumina Inc (ILMN) - GuruFocus
Scott Gottlieb Buys 200 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
Ngs Oncology Market Is Going to Boom | Illumina • Roche • Thermo Fisher Scientific - openPR.com
Can Illumina Inc. (ILU) stock expand revenue streams2025 Bull vs Bear & Comprehensive Market Scan Insights - mfd.ru
Simplifying library prep: All in a day’s work for Louise Fraser - Illumina
Illumina Looks To Clinical Consumables And China Restart To Offset Intensifying NGS Price Pressure - Citeline News & Insights
Spatial Genomics and Transcriptomics Market size to cross - openPR.com
Illumina, Inc. $ILMN Shares Sold by GUARDCAP ASSET MANAGEMENT Ltd - MarketBeat
Multiomics Market Forecast Through 2033: Size, Share, Trends, - openPR.com
My path to Illumina - Illumina
Unlocking Illumina (ILMN) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
This Week in Chancery Court: Trump Media SPAC Appeal, Illumina - Bloomberg Law News
Illumina Crash 10% on Earnings: Why the Stock Could Rebound to $185 in 2026 - TIKR.com
Illumina, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - 富途牛牛
Diamond Hill Capital Management Inc. Has $32.57 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Is Illumina’s (ILMN) Clinical Consumables Surge Quietly Redefining Its Core Investment Story? - Yahoo Finance
Illumina (ILMN) Gets a Sell from Barclays - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Ocular Therapeutix (OCUL) - The Globe and Mail
Illumina (ILMN) stock slides 10% after 2026 outlook puts China, research demand back in focus - TechStock²
Illumina, Inc.'s (NASDAQ:ILMN) Business Is Yet to Catch Up With Its Share Price - 富途牛牛
Illumina Enters Oversold Territory (ILMN) - Nasdaq
UBS Adjusts Illumina Price Target to $135 From $120, Maintains Neutral Rating - marketscreener.com
Molina Healthcare, Coty, Illumina, Amazon and other big stocks moving lower in Friday's pre-market session - MSN
Principal Financial Group Inc. Sells 17,431 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript - Insider Monkey
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina revenue up 5% to USD 1.16B in Q4 2025 - Medical Buyer
ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum - Yahoo Finance
Illumina Inc (ILMN) Q4 2025 Earnings Call Highlights: Strong Clinical Growth Amidst Research ... By GuruFocus - Investing.com Canada
Earnings call transcript: Illumina beats Q4 2025 EPS forecast by 10.66% - Investing.com Nigeria
Illumina Q4 2025 slides: Clinical growth accelerates as NovaSeq X transition advances - Investing.com South Africa
Illumina Q4 Earnings Call Highlights - Yahoo Finance
Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Illumina Inc (NASDAQ:ILMN) Stock Falls Despite Q4 Earnings Beat on Cautious 2026 Outlook - Chartmill
Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
0.54%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):